Literature DB >> 7172477

A total population study of diagnosed chromosome abnormalities in Queensland, Australia.

J Bell, J Pearn, C McCarthy, L Jones, C Trouton, F Hunt, L Berry.   

Abstract

Aneuploidy and structural chromosome rearrangements comprise a significant group of abnormalities in the general population. The true incidence of such abnormalities can be obtained by large research studies of consecutive newborns. In practice, the observed incidence of such chromosome abnormalities is obtained by karyotyping subjects who present for clinical reasons. The difference between the observed clinically indicated rates and the assumed rate (by comparison with data from consecutive newborn studies) would allow the estimation of the unrecognised chromosome abnormality load in the general population. The difference between these two rates would provide valuable data concerning the appropriateness of selection techniques for routine chromosome analysis. This paper reports such a study, from Queensland, Australia. A total population 5-year survey (1976-1980) of the diagnosed chromosome abnormalities in this unselected primary population of 2.2 million people is reported. Five hundred and eighty-nine chromosome abnormalities were detected in a consecutive series of 6092 karyotypes performed (9.7%). This figure is significantly lower than that found in most other reported series where case selection for karyotyping is determined by clinical criteria. In this current study the annual diagnostic rate for chromosome abnormalities was 5.41 per 100,000 of the general population. Cumulative frequency histograms for all types of chromosome abnormality, by age, are presented. In current practice, 32% of chromosome abnormalities are not diagnosed until adult life. Fifty percent of cases of chromosome abnormality (of all types) remain undiagnosed by the age of 1 year, in spite of a relatively liberal acceptance rate on the part of laboratories offering routine karyotyping services. It is concluded that a positive diagnostic rate greater than 10%, in routine chromosome laboratories, probably indicates that more than half the true cases of chromosome abnormality in a population are being missed.

Entities:  

Mesh:

Year:  1982        PMID: 7172477     DOI: 10.1111/j.1399-0004.1982.tb01411.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  3 in total

1.  Childhood deaths in Down's syndrome. Survival curves and causes of death from a total population study in Queensland, Australia, 1976 to 1985.

Authors:  J A Bell; J H Pearn; D Firman
Journal:  J Med Genet       Date:  1989-12       Impact factor: 6.318

2.  Rare chromosome abnormalities, prevalence and prenatal diagnosis rates from population-based congenital anomaly registers in Europe.

Authors:  Diana Wellesley; Helen Dolk; Patricia A Boyd; Ruth Greenlees; Martin Haeusler; Vera Nelen; Ester Garne; Babak Khoshnood; Berenice Doray; Anke Rissmann; Carmel Mullaney; Elisa Calzolari; Marian Bakker; Joaquin Salvador; Marie-Claude Addor; Elizabeth Draper; Judith Rankin; David Tucker
Journal:  Eur J Hum Genet       Date:  2012-01-11       Impact factor: 4.246

3.  Heteromorphic variants of chromosome 9.

Authors:  Nadezda Kosyakova; Ani Grigorian; Thomas Liehr; Marina Manvelyan; Isabella Simonyan; Hasmik Mkrtchyan; Rouben Aroutiounian; Anna D Polityko; Anna I Kulpanovich; Tatiana Egorova; Evgenia Jaroshevich; Alla Frolova; Natalia Shorokh; Irina V Naumchik; Marianne Volleth; Isolde Schreyer; Heike Nelle; Markus Stumm; Rolf-Dieter Wegner; Gisela Reising-Ackermann; Martina Merkas; Lukretija Brecevic; Thomas Martin; Laura Rodríguez; Samarth Bhatt; Monika Ziegler; Katharina Kreskowski; Anja Weise; Ali Sazci; Svetlana Vorsanova; Marcelo de Bello Cioffi; Emel Ergul
Journal:  Mol Cytogenet       Date:  2013-04-01       Impact factor: 2.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.